| 000 | 01801 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517233319.0 | ||
| 264 | 0 | _c20181211 | |
| 008 | 201812s 0 0 eng d | ||
| 022 | _a1932-8737 | ||
| 024 | 7 |
_a10.1002/clc.23052 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEdward, Justin A | |
| 245 | 0 | 0 |
_aIntravenous regadenoson with aminophylline reversal is safe and equivalent to intravenous adenosine infusion for fractional flow reserve measurements. _h[electronic resource] |
| 260 |
_bClinical cardiology _cOct 2018 |
||
| 300 |
_a1348-1352 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAdenosine _xadministration & dosage |
| 650 | 0 | 4 |
_aAdenosine A2 Receptor Agonists _xadministration & dosage |
| 650 | 0 | 4 |
_aAminophylline _xadministration & dosage |
| 650 | 0 | 4 |
_aCardiotonic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCoronary Angiography _xmethods |
| 650 | 0 | 4 |
_aCoronary Stenosis _xdiagnosis |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aFractional Flow Reserve, Myocardial _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPurines _xadministration & dosage |
| 650 | 0 | 4 |
_aPyrazoles _xadministration & dosage |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aVasodilator Agents _xadministration & dosage |
| 700 | 1 | _aLee, John H | |
| 700 | 1 | _aWhite, Christopher J | |
| 700 | 1 | _aMorin, Daniel P | |
| 700 | 1 | _aBober, Robert | |
| 773 | 0 |
_tClinical cardiology _gvol. 41 _gno. 10 _gp. 1348-1352 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/clc.23052 _zAvailable from publisher's website |
| 999 |
_c28747271 _d28747271 |
||